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CCR2-/- knockout mice revascularize normally in
response to severe hindlimb ischemia
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Objective: Monocyte chemoattractant protein-1 (MCP-1) is reported to stimulate ischemia-induced arteriogenesis
(collateral artery development) by recruiting monocytes and macrophages into areas of active arteriogenesis. To
determine whether the MCP-1–mediated response occurs through its receptor, CC-chemokine receptor 2 (CCR2), we
induced hindlimb ischemia in mice lacking the receptor for MCP-1 (CCR2-/-) and measured limb blood flow recovery,
collateral artery development, and monocyte and macrophage recruitment.
Methods and results: Hindlimb ischemia was induced by excising the left femoral artery in CCR2-/- and wild-type mice.
Hindlimb blood flow recovery, as measured using laser Doppler perfusion imaging, was equivalent in both groups (P 
.78 for foot and P  0.38 for calf). Collateral artery development, as measured by angiography at postoperative day 14
and 31, likewise did not differ between the 2 groups (P  .46 and P  .67). Counts of monocytes and macrophages in
calf and thigh muscle sections of mice sacrificed on postoperative day 7 revealed that although CCR2-/- mice recruited
44% fewer monocytes and macrophages to areas of ischemia in the calf, they recruited similar numbers of monocytes and
macrophages to areas of active arteriogenesis in the thigh. Intercellular adhesion molecule-1 and MCP-1 mRNA levels
were higher in the thigh muscle of CCR2-/- mice than in wild-type mice (5.5-fold and 42.3-fold induction operated to
unoperated vs 2.6-fold and 6.1-fold induction operated to unoperated, respectively).
Conclusions: Blood flow recovery, arteriogenesis, and monocyte and macrophage recruitment to the thigh was normal in
CCR2-/- mice. However, monocyte and macrophage recruitment to the ischemic calf was diminished in CCR2-/- mice.
Our results show that MCP-1 signaling through CCR2 is not required for physiologic arteriogenesis in response to severe
hindlimb ischemia. ICAM-1 upregulation may substitute for MCP-1 signaling through CCR2 in order to allow normal
arteriogenesis in CCR2-/- mice. ( J Vasc Surg 2004;40:786-95.)
Clinical Relevance: Arteriogenesis, or collateral artery development, is required for recovery from acute or chronic limb
ischemia. To develop molecular therapies to treat limb ischemia caused by peripheral vascular occlusive disease,
researchers have studied the mechanisms behind arteriogenesis. Macrophages and monocytes have been shown to
stimulate arteriogenesis in several animal models, as has one of their chemoattractants, MCP-1. Because MCP-1 has been
proposed as a possible molecular therapy for peripheral vascular occlusive disease, we studied whether mice lacking the
receptor for MCP-1 could undergo normal arteriogenesis after hindlimb ischemia.A better understanding of the mechanisms by which
hindlimb ischemia induces collateral artery development,
or arteriogenesis, is required to direct the development of
new therapies for atherosclerotic occlusive disease. Arterio-
genesis is critical for limb preservation after ischemic injury.
Recent studies suggest that circulating monocytes play a
critical role in ischemia-induced arteriogenesis.1-4 Mono-
cytes are recruited to regions of active arteriogenesis, where
they are thought to secrete growth factors and other bio-
active molecules that promote the proliferation and migra-
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doi:10.1016/j.jvs.2004.07.012786tion of endothelial and hindlimb ischemia, the smooth
muscle cells. The number of monocytes and macrophages
recruited to areas of active arteriogenesis after induction of
hindlimb ischemia in pig and rabbit models has been cor-
related to the degree of restoration of blood flow.5 It has
recently has been suggested that vascular endothelial
growth factor (VEGF) and placental growth factor (PlGF)
promote arteriogenesis by recruiting monocytes.6 The
ICAM-1/Mac-1 pathway has also been shown to promote
arteriogenesis by means of monocytes.7 Transplantation of
exogenous monocytes also promotes arteriogenesis.8 The
mechanism by which monocytes are recruited to areas of
active arteriogenesis and their exact role in stimulating
arteriogenesis, however, is not completely understood.
Induction of hindlimb ischemia in the mouse has been
used extensively to study the molecular mechanisms lead-
ing to arteriogenesis.9 Both femoral artery excision,9-12
which induces muscle necrosis, inflammation, and regener-
ation, as well as femoral artery ligation13 have been used as
models of hindlimb ischemia.
Monocyte chemoattractant protein-1 (MCP-1, also
called CCL2), a member of the chemokine (chemotactic
cytokine) family, potently induces monocytes to migrate to
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delivered either intra-arterially or by mini-osmotic pump,
has been shown to increase collateral artery development in
hindlimb models of ischemia.2,3,15,16 MCP-1 attracts
monocytes and macrophages by acting as the ligand for
activation of chemokine receptor 2 (CCR2), which also
serves as the primary receptor for the closely related che-
mokines MCP-2, MCP-3, and MCP-5.17 To date, no other
monocyte or macrophage receptor for MCP-1 has been
identified definitively. CCR2-null (CCR2-/-) mice have
profound deficits in the recruitment of monocytes and
macrophages to sites of inflammation or injury, despite
normal numbers of both circulating monocytes and resi-
dent tissue macrophages.18
If MCP-1 directed recruitment of monocytes and mac-
rophages is required for normal physiologic arteriogenesis
in response to hindlimb ischemia, we hypothesized that
CCR2-/- mice should recover limb blood flow more slowly
and/or less completely than wild-type mice, as recently
reported.19 To test this hypothesis, we induced severe
hindlimb ischemia in wild-type and CCR2-/- mice by fem-
oral artery excision. We then studied blood flow recovery
by laser Doppler perfusion imaging and collateral artery
development by angiography. We also measured monocyte
and macrophage recruitment to areas of ischemic muscle
(calf) and areas of active arteriogenesis (thigh).
MATERIAL AND METHODS
Animals. The 73 mixed-gender, 3- to 5-month-old
wild-type or CCR2-/-18C57Bl/6 mice, weighing 18 to
27 g, were backcrossed onto C56Bl/6 for at least 10
generations; littermate controls were used when avail-
able (approximately 80% of all control mice; 20% of
control mice were wild-type C57Bl/6 mice purchased
from Charles River). Mice were housed in an environ-
mentally controlled room and were fed chow and water
ad libitum. The care of mice complied with the National
Research Council’s Guide for the Care and Use of Labo-
ratory Animals. All protocols were approved in accor-
dance with the Committee on Animal Research at the
University of California, San Francisco.
Study design. Severe hindlimb ischemia was in-
duced by excising the left femoral artery of wild-type (n
 32) and CCR2-/- (n  33) C57Bl/6 mice. Mice were
sacrificed on postoperative days 7, 14, and 31. Mice
sacrificed at postoperative day 31 were studied sequen-
tially by laser Doppler perfusion imaging (n  16 per
group). Muscle from the mice sacrificed on postoperative
day 7 (n  6 per group) was harvested, weighed, and
stained for monocytes and macrophages. Angiograms
were performed on postoperative days 14 (n  3 wild-
type, n  4 CCR2-/-) and 31 (n  7 per group).
Moderate hindlimb ischemia was induced by ligating the
left femoral artery on a subset of mice (n  4 per group).
These mice were studied sequentially by laser Doppler
perfusion imaging, and angiograms were performed on
postoperative day 31.Mouse hindlimb ischemia models. Left femoral ar-
tery excision was performed as described previously.9
Briefly, mice were anesthetized using 2% isoflurane inha-
lation, delivered under a constant oxygen flow rate of 1
L/min. A longitudinal incision was made over the left
groin, and the left femoral artery and its associated
branches were isolated from the inguinal ligament to the
saphenous-popliteal bifurcation. The femoral artery and
branches were ligated using 5-0 silk ties, and excised
from the inguinal ligament up to and including the
saphenous-popliteal bifurcation. The wound was then
closed using an Autoclip stapler.
Moderate hindlimb ischemia was induced by left
femoral artery ligation between the superficial epigastric
artery and the saphenous-popliteal bifurcation. The fem-
oral artery was singly ligated using a 5-0 silk tie, and the
wound was closed using an Autoclip stapler. Extent of
ligation or excision is diagrammed in Fig 1.
Laser Doppler perfusion imaging. Mice were anes-
thetized using 1.5% isoflurane anesthesia by face mask,
delivered under a constant oxygen flow rate of 1 L/min.
A subset of mice was anesthetized using ketamine
(100mg/kg intraperitoneal [IP]) and xylazine (13mg/kg
IP). Hair was removed using an electrical shaver followed
by Surgi-Prep depilatory cream (Sparta Surgical, Roseville,
Calif). A Laser Doppler perfusion imager (Moor Instru-
ments Ltd, Devon, United Kingdom) was used to measure
dermal blood flow in the dorsal calf and footpad on post-
operative days 3, 7, 14, 21, 28, and 31. Perfusion ratios of
the operated over contralateral nonoperated hindlimb (av-
eraged over 3 scans) were compared to minimize differ-
ences between ambient temperature and lighting. Mice
were maintained between 36.8° and 37.2°C during scan-
ning with a homeothermic warming pad. If a group of scans
varied by more than 20% in absolute perfusion ratio, the
group was discarded, and the mouse underwent repeat
scanning.
Angiography. Mice were anesthetized with 2% in-
haled isoflurane as described previously. The infrarenal
abdominal aorta was ligated proximally and canulated
distally with a 24G polyethylene catheter. Warmed hep-
arinized saline (10 U/mL, 0.4 mL total volume) was
injected into the aortic catheter. Barium sulfate (0.6 g/mL,
EZpaque), 0.3 mL, was then injected into the aortic catheter,
and the aorta and vena cava were ligated. The skin was
removed from the mouse hindlimbs to avoid imaging the
dermal vasculature. Images were acquired by using a single
enveloped Kodak X-OMAT TL film at 500 mA, 50 kV, and
0.5 sec exposure. Mice were sacrificed prior to imaging. Three
blinded observers independently scored the images by count-
ing the number of vessels that crossed a standardized grid
overlying the image. The number of vessels was then divided
by the lines of the grid in the area of interest to produce an
angioscore.
Tissue preparation. Mice were sacrificed by CO2
inhalation followed by cervical dislocation. The tibialis
anterior (TA), gastrocnemius (GC) and en-bloc thigh
musculature from the right and left sides were harvested
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sections of muscle were processed into Tissue-Tek Op-
timal Cutting Temperature compound (Fisher Scientific,
Pittsburgh, Pa) for immunohistochemical analysis.
Immunohistochemistry. Immunohistochemistry
was performed on 10 m frozen muscle sections of the
gastrocnemius and the thigh musculature in 6 mice per
group on postoperative day 7. Three separate areas at
least 60 m apart were stained per muscle to provide a
representative sample. Arteries were stained using a pri-
mary rat monoclonal antibody to the endothelial cell
maker CD31 (PECAM-1, 1:100 dilution; Pharmingen,
Fig 1. Mouse hindlimb ischemia models. A, Severe h
diagrammed. Dashed line indicates level at which mu
immunohistochemistry. B, Mild hindlimb ischemia wa
diagram.San Diego, Calif) and an alkaline phosphatase– conju-
gated primary mouse monoclonal antibody to smooth
muscle -actin (Sigma, St Louis, Mo). Macrophages and
monocytes were stained using a primary rat monoclonal
antibody to the monocyte/macrophage marker
MOMA-2 (1:400 dilution; Serotec, Oxford, United
Kingdom). CD31 and MOMA-2 antibodies were de-
tected using a biotinylated rabbit anti-rat, mouse-ad-
sorbed secondary antibody (1:250 dilution; Pharmin-
gen), a streptavidin-horseradish peroxidase conjugate, or
the ABC amplification kit per manufacturer’s instruc-
tions (Vector Labs, Burlingame, Calif), and developed
b ischemia was induced by femoral artery excision as
sections for the thigh were harvested for MOMA-2
ced by femoral artery ligation as shown by simplifiedindlim
scle
s indu
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Labs). Smooth muscle -actin was detected using the
NBT-BCIP alkaline phosphatase substrate per manufac-
turer’s instructions (Vector Labs). Slides were counter-
stained with eosin. Arteries were quantified by averaging
the total number of smooth muscle -actin, CD31 dou-
ble-positive nonvenous vascular structures per low-pow-
ered field in 3 separate fields per section. Artery diame-
ters were quantified by averaging the diameters of the 5
largest arteries (as defined previously) per low-powered
field in 3 separate fields per section. Monocytes and
macrophages were quantified by averaging the total
number of stained cells per high-powered field in 3
separate fields containing morphologically identifiable
arteries or arterioles (as determined by the presence of an
internal elastic lamina layer). Perivascular monocytes and
macrophages, as defined by stained cells outside the
arterial or arteriolar lumen but within the adventitia,
were also counted in the same fields.
Quantitative real-time PCR (qRT-PCR). Total
RNA was isolated from snap-frozen thigh muscle using
TRIZOL reagent (Invitrogen, Carlsbad, Calif) per man-
ufacturers’ instructions, followed by DNase I (Roche,
Indianapolis, Ind) treatment, further purification via
Qiagen RNeasy mini-kit per manufacturers’ instructions
(Qiagen, Valencia, Calif), and storage at –80°C. First
strand cDNA synthesis was performed on 1.5 g total
RNA using random primers (Invitrogen) by Superscript
III reverse transcriptase (Invitrogen) in a 20-L reac-
tion. The cDNA was diluted 1:20 prior to PCR amplifi-
cation. Quantitative real-time PCR was performed in a
25-L volume with 200nmol/L primers and SYBR
Green fluorescent dye. Reactions were performed using a
MJ Opticon-2 real time PCR machine and software
according to the manufacturer’s instructions (MJ Re-
search, Waltham, Mass). PCR conditions were as fol-
lows: 3-minute at 94°C denaturation step followed by 40
cycles of 10 seconds at 94°C denaturation, 15 seconds at
60°C annealing, and 20 seconds at 72°C extension.
Amplification specificity was confirmed by melting curve
analysis and agarose gel electrophoresis. Primers were as
follows: MCP-1 forward 5=-TTGGCTCAGCCAGATG-
CAGT-3=, reverse 5=CCAGCCTACTCATTGGGATCAT-
3=; ICAM forward 5=-TGTATTCGTTTCCGGAGAGTG-
3=, reverse 5=-GTGATCTCCTTGGGGTCCTT-3=; and
reference gene 18s rRNA forward 5=-CGG CTA CCA CAT
CCA AGG AA-3=, reverse 5=-GCT GGA ATT ACC GCG
GCT-3=. Gene expression levels were normalized using the
18s rRNA Ct using the following formula: [1  Efficiency
primers of gene of interest]^(–Ct gene of interest)/[1 
Efficiency primers 18s rRNA]^(–Ct 18s rRNA). Primer effi-
ciencies, as determined by dilution curve analysis, were as
follows: MCP-1 2, ICAM 2, and 18s rRNA 2.
Statistical analysis. All results are expressed as the
mean  standard error of the mean (SEM). Statistical
significance was determined using the Student t test for
comparison between 2 groups or repeated measures analy-sis of variance for comparison over a time course. A value of
P  .05 was considered to be statistically significant.
RESULTS
CCR2-/- mice recover hindlimb blood flow after
induction of hindlimb ischemia. Laser Doppler perfu-
sion ratios were calculated in wild-type and CCR2-/- mice
in the footpad and the calf (Fig 2, A for source images). An
initial pilot study of wild-type and CCR2-/- mice (n 9 per
group) showed no difference in perfusion ratios up to 45
days after induction of severe hindlimb ischemia. A second
series of mice (n  7 per group) was then followed for 31
days and afterwards sacrificed for angiography. At 31 days
after the induction of severe hindlimb ischemia by femoral
artery excision, both wild-type and CCR2-/- mice recov-
ered blood flow in the footpad and in the calf at the same
rate and to a similar degree (Fig 2, B). To confirm this
finding and to rule out the possibility that our results were
confounded by the muscle necrosis and inflammation in-
duced by femoral artery excision, we induced moderate
hindlimb ischemia by femoral artery ligation in a subset of
wild-type and CCR2-/- mice (n  4 per group). Both
groups of mice had equivalent blood flow recovery in both
the footpad and the calf after femoral artery ligation (data
not shown).
CCR2-/- mice have normal arteriogenesis after in-
duction of hindlimb ischemia. Angiography was per-
formed at early (postoperative day 14) and late (postoper-
ative day 31) time points after ischemia. As shown in Fig 3,
A, both CCR2-/- and wild type mice developed extensive
collateral arteries bridging the area of excised artery. When
rated by 3 blinded observers, angioscores of the wild-type
and the CCR2-/- mice were not significantly different (P
.46 and P .67, respectively; Fig 3, B). Diameter measure-
ments of the 5 largest collaterals in each angiogram were
not different between wild-type and CCR2-/- mice (P 
.52, data not shown). After femoral artery ligation, both
groups of mice had equivalent angioscores at postoperative
day 31 (P  .72, data not shown). When collateral arteries
were assessed by immunohistochemistry, both groups also
had increased collateral artery diameters over the right side
(P  .05, data not shown), but there was no significant
difference between the increase in diameter between wild-
type and CCR2-/- mice. There was a trend for increased
artery density in wild-type and CCR2-/- mice over the
unoperated side, but this increase was not statistically sig-
nificant (P  .089)
Increased edema in calf skeletal muscle in CCR2-/-
mice after induction of hindlimb ischemia. Calf muscle
mass was significantly greater in CCR2-/- mice than wild-
type mice at postoperative day 7 (P  .05; Fig. 4, A, B).
Analysis of muscle sections from the calf at this time point
by hematoxylin and eosin staining revealed increased
edema in the calf (Fig 4, C). These differences in muscle
mass persisted through postoperative day 14, but resolved
by postoperative day 31. These results suggest that the
CCR2-/- mice underwent the same degree of muscle re-
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response to severe hindlimb ischemia.
Monocyte and macrophage recruitment is impaired
in CCR2-/- mice after induction of hindlimb ischemia.
Total monocyte and macrophage counts were lower in
the operated calf of CCR2-/- mice after induction of
severe hindlimb ischemia than in wild-type mice (oper-
ated 116.5 20.4 vs unoperated 85 9.5, and operated
184.8  19.9 vs unoperated 110.6  10.3, respectively;
P  .05), although CCR2-/- mice did recruit more
monocytes and macrophages to the operated calf than
did unoperated controls (Fig 5, A). There was no differ-
ence in the number of monocytes and macrophages in
the operated thigh between wild-type and CCR2-/-
mice, although both recruited more perivascular mono-
cytes and macrophages to the operated thigh than to the
Fig 2. CCR2-/- mice recover blood flow normally follow
picture showing anesthetized mouse positioned for las
Doppler perfusion scanned images at postoperative day 3
(yellow) regions of interest outlined. B, Footpad (left pan
(solid squares, n  16) and CCR2-/- mice (open circles, n
hindlimb ischemia as measured by laser Doppler perfusio
respectively).contralateral thigh or the thighs of unoperated mice (Fig
5, A). CCR2-/- mice had fewer perivascular monocytes
and macrophages in the operated calf than did wild-type
mice, but no differences were seen in the thigh (Fig 5,
B). Both wild-type and CCR2-/- mice recruited more
perivascular monocytes and macrophages to the oper-
ated thigh than to the unoperated right leg, and both
types of mice recruited more than the unoperated mouse
controls, demonstrating that monocyte influx into areas un-
dergoing active arteriogenesis is not dependent on CCR2.
ICAM-1 and MCP-1 expression are increased in
CCR2-/- mice after induction of hindlimb ischemia.
Recently Hoefer et al7 presented evidence showing that
ICAM-1-blocking antibodies totally blocked MCP-1’s ef-
fect on increasing arteriogenesis. We therefore examined
the expression levels of ICAM-1 in the thigh—the area of
nduction of mild or severe hindlimb ischemia. A, Digital
ppler perfusion imaging (left) and representative laser
wild-type and CCR2-/- mice with footpad (red) and calf
nd calf (right panel) recovery of blood flow by wild type
) were equivalent over 31 days after induction of severe
aging under isoflurane anesthesia (P  .78 and P  .38,ing i
er Do
1 in
el) a
 16
n im
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qRT-PCR. CCR2-/- mice had a greater induction than
wild-type mice of ICAM-1 mRNA in the operated thigh
muscle as compared with the unoperated thigh (5.5-fold
induction vs 2.6-fold induction, respectively; P  .5). We
also examined the expression levels of MCP-1 mRNA in the
Fig 3. Angioscores of wild-type and CCR2-/- mice are
angiograms of wild-type and CCR2-/- mice at postopera
mice (n  4) at postoperative day 14 and at postoperativ
different (4.37  0.46 vs 5.08  0.73, P  .46, and 6.3thigh, in order to confirm that MCP-1 was upregulated in
both wild type and CCR2-/- mice. By qRT-PCR, CCR2-/-
mice had a greater induction than wild-type mice of MCP-1
mRNA in the operated thigh muscle compared with the
unoperated thigh (42.3-fold induction vs 6.1-fold induc-
tion, respectively; P  .5).
alent at postoperative days 14 and 31. A, Representative
ay 31. B, Angioscores of wild-type (n  3) or CCR2-/-
31 (n  7 per group, right panel) were not statistically
0.0.66 vs 5.97  0.58, P  .67, respectively)equiv
tive d
e day
5 
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In this study we used a mouse model of severe
hindlimb ischemia to determine whether MCP-1 signal-
ing through CCR2 is required for physiologic arterio-
genesis. There are 4 major conclusions from these exper-
iments. First, CCR2 is not required for recovery of
dermal blood flow, as determined by sequential laser
Doppler measurement. Second, CCR2 is not required
for the development of collateral vessels, as determined
by angiography and by histologic vessel counts and
diameters. Third, CCR2 is not required for monocyte
and macrophage recruitment to the thigh, the area where
collateral vessels are actively developing. Fourth, CCR2
does play a role in monocyte and macrophage recruit-
ment to the calf, an area of severe ischemia. We conclude
from these results that the MCP-1/CCR2 pathway is not
essential for normal arteriogenesis in response to severe
hindlimb ischemia.
MCP-1 is the most potent and best-characterized
monocyte chemoattractant.20 Recent studies using either
Fig 4. CCR2-/- hindlimb skeletal muscle develops inc
anterior (A) and gastrocnemius muscle mass (B), present
muscle mass, is significantly increased secondary to inc
postoperative day 7 (n  6 per group, 1.81  0.20 vs 0
.03, respectively). Muscle mass recovery at postoperativ
wild-type and n  4 CCR2-/- mice, 0.97  0.04 vs 1.05
for postoperative day 14; n 7 wild-type and n 4 CCR
0.14 vs 1.00  0.08, P  .64, for postoperative day 31)
stained with hematoxylin and eosin demonstrate increasneutralizing antibodies or mice genetically deficient in ei-
ther MCP-1 or its receptor, CCR2, have provided compel-
ling evidence that this chemokine is critical for monocyte
and macrophage recruitment in peritonitis,18 experimental
autoimmune encephalitis,21,22 rheumatoid arthritis,23 tu-
berculosis,24 atherosclerosis,25 and restenosis following an-
gioplasty.26 The importance of monocytes in collateral
artery growth was demonstrated by Heil et al,5 who used
5-fluorouracil to manipulate the peripheral blood mono-
cytes and found a good correlation between the monocyte
count and blood flow recovery after femoral artery ligation.
Moreover, during the phase of monocyte depletion, blood
flow was improved by the direct injection of isolated mono-
cytes. More recently, transplantation of monocytes has
been reported to accelerate arteriogenesis, although this
finding was in the context of allogeneic monocytes whereas
autologous monocytes had no effect.8
It is logical, therefore, to hypothesize that MCP-1
would play an important role in collateral artery develop-
ment after ischemic injury by promoting monocyte and
d edema after induction of hindlimb ischemia. Tibialis
the ratio between left (operated) and right (unoperated)
skeletal muscle edema over wild-type muscle mass at
0.08, P  .009, and 1.44  0.20 vs 0.78  0.02, P 
s 14 and 31 is equivalent between the 2 groups (n  3
03, P  .22, and 0.89  0.10 vs 0.96  0.03, P  .51,
mice, 1.00 0.08 vs 1.12 0.09, P .35, and 0.91
resentative photomicrographs of gastrocnemius muscle
ema in CCR2-/- muscle at postoperative day 7 (C).rease
ed as
reased
.78 
e day
 0.
2-/-
. Rep
ed ed
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direct support for this notion. Ito et al3 initially demon-
strated that local administration of MCP-1 into the collat-
eral circulation using an osmotic minipump promoted col-
Fig 5. Ischemia-induced monocyte/macrophage recru
I) and CCR2-/- (B, D, F, H, J) muscle sections staine
indicate representative intraluminal MOMA-2 cells. Arr
A, B, Unoperated gastrocnemius muscle. C, D, Righ
G, H, Right thigh muscle. I, J, Left thigh muscle. K, T
were significantly higher in the ischemic calf and distal th
than in the ischemic calf and distal thigh of CCR2-/- m
CCR2-/- mice vs 40  15.6 in unoperated wild-type mic
4.2 in unoperated wild-type mice, respectively, *P  .
Perivascular MOMA-2 positive staining cells were signific
left femoral artery excision than in the ischemic calf of ei
0.3 or 5.3  2.5, respectively; *P  .05 vs unoperated clateral development. This finding was repeated by van
Royen et al15 in the hyperlipidemic Watanabe rabbit. The
benefit was transient, however, and by 6 months collateral
artery formation was equivalent in rabbits that received
t is decreased in CCR2-/- mice. Wild type (A, C, E, G,
the monocyte/macrophage marker MOMA-2. Arrows
ads indicate representative perivascular MOMA-2 cells.
trocnemius muscle. E, F, Left gastrocnemius muscle.
MOMA-2 positive staining cells per high-powered field
f wild-type mice 7 days after left femoral artery excision
r unoperated mice (184.8  19.9 vs 110.6  10.3 in
d 116.5  20.4 vs 85  9.5 in CCR2-/- mice vs 27.3 
unoperated control; #P  .05 vs CCR2-/- mice). L,
higher in the ischemic calf of wild-type mice 7 days after
CR2-/- mice or unoperated mice (10.0  1.7 vs 7.9 
l; #P  .05 vs CCR2-/- mice).itmen
d for
owhe
t gas
otal
igh o
ice o
e, an
05 vs
antly
ther C
ontro
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that local infusion of MCP-1 significantly increased blood
flow and collateral conductance, after femoral artery liga-
tion. Recently, van Royen et al2 showed that local infusion
of MCP-1 into apoE-/- mice increased collateral artery
formation and blood flow in the hindlimb ischemia model
after femoral ligation, but, troublingly, also increased ath-
erosclerotic plaque progression. Taken together, these data
demonstrate that MCP-1 plays a functional role in restora-
tion of blood flow following ischemia, but they do not
provide evidence that the mechanism is through the re-
cruitment of monocytes and macrophages. The recent
availability of mice genetically altered to lack either MCP-1
or its receptor, CCR2, allowed us to directly address this
question.
The conclusions of our study differ sharply from those
recently reported by Heil et al,5 who also chose to study the
reponse of CCR2-/- mice to hindlimb ischemia to elucidate
the role of monocytes and macrophages in arteriogenesis.
Heil et al demonstrated that Balb/c CCR2-/- mice had 50%
less recovery of blood flow after femoral artery ligation than
wild-type mice. However, in C57Bl/6 CCR2-/- mice, the
strain of mice used in this study, the difference was only
10% at a single time point. Balb/c mice exhibit a Th2
cytokine response and are less prone to inflammation than
C57Bl/6 mice, which have a Th1 cytokine response and
produce more interferon. Therefore, C57Bl/6 mice have
been the preferred strain to study atherosclerosis and other
disease models in which inflammation is thought to play a
prominent role such as the response to acute ischemia. We
suspect that the more intense ischemia and inflammation
caused by femoral artery excision used in our study as well
as the well-known strain differences between mice may
explain the discrepancy between our 2 studies.
As noted previously, all studies to date have failed to
demonstrate an MCP-1–dependent response in monocytes
and macrophages obtained from CCR2-/- mice. However,
smooth muscle cells have been shown to respond to MCP-1
in a CCR2-independent manner. Schecter et al27 demon-
strated that MCP-1 induces tissue factor production in human
aortic smooth muscle cells, and these cells have neither CCR2
protein nor mRNA. Recent studies have confirmed these
findings by showing that aortic smooth muscle cells from
CCR2-/- mice also respond to MCP-1 by inducing the pro-
duction of tissue factor.28 This effect of MCP-1 is likely
through VEGF-A, as MCP-1’s mitogenic effects on vascular
smooth muscle can be blocked by anti–VEGF-A antibodies.29
This result raises the interesting possibility that the increased
arteriogenesis seen in response to infusion of MCP-12,3,15,16
is due to effects on vascular smooth muscle rather than due to
signaling through CCR2. Consistent with this possibility is
the fact that we saw no detriment in the CCR2-/- mice in
recruitment of perivascular monocytes and macrophages to
the thigh, which is the area where the collateral vessels were
developing.
MCP-1 is upregulated in sites of inflammation, injury,
or ischemia,20 and so it was not surprising to find that fewer
macrophages were recruited to the severely ischemic gas-trocnemius muscle of the calf in the CCR2-/- mice. The
finding that blood flow to the foot, as measured by laser
Doppler scanning, was the same in CCR2-/- mice and
control wild-type mice suggests that macrophage recruit-
ment to these calf muscles does not play an important role
in restoration of distal blood flow. We failed to detect any
difference in macrophage recruitment to the perivascular
areas in the thigh in CCR2-/- mice, even though both
contained more macrophages than the contralateral, unop-
erated muscles. These data suggest that either chemokines
other than MCP-1 are responsible for the influx of macro-
phages or that MCP-1 can recruit monocytes and macro-
phages independent of CCR2. In support of our data,
MCP-1’s effect on arteriogenesis has been shown to pro-
ceed via an ICAM-1/Mac1 mediated mechanism.7 Our
finding that ICAM-1 was upregulated more in CCR2-/-
mice than in wild-type mice may explain why we observed
no difference in arteriogenesis. The ICAM-1/Mac-1 path-
way could have caused the equivalent monocyte and mac-
rophage recruitment in the CCR2-/- and wild-type mice. If
this were true, the high levels of MCP-1 seen in the
CCR2-/- mice could lead to ICAM-1 upregulation on
endothelial cells in a CCR2-independent mechanism. In-
creased transmigration of monocytes would then occur in
response to the ICAM-1 upregulation in areas of active
arteriogenesis.
We conclude that CCR2 does not significantly contrib-
ute to arteriogenesis in response to acute severe hindlimb
ischemia. Our results suggest that a 44% decrease in mono-
cyte and macrophage recruitment to the area of severe
ischemia is not sufficient to disrupt physiological arterio-
genesis, which appears to operate through a mechanism
independent of CCR2. Further studies on the exact mech-
anism by which overexpression of MCP-1 stimulates arte-
riogenesis are needed, whether by monocyte and macro-
phage recruitment, possibly through upregulation of
endothelial ICAM-1, or by direct effects on vascular
smooth muscle. In light of the finding that MCP-1 both
increases arteriogenesis but also increases progression of
atherosclerosis,2 any therapy involving the use of MCP-1 to
stimulate collateral artery growth in patients with periph-
eral vascular occlusive disease resulting from atherosclerosis
must approached with caution.
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